WE ARE EXCITED

about the expansion of our federally-qualified Medicare Contracting Prescription Drug Plan product offering for our clients and their members. Share a clear view of our Medicare Part D site and how we deliver exceptional performance via our full pass-through business model.

On March 9, 2016

Hospira, Inc., a Pfizer company, recalled 8.4% Sodium Bicarbonate Injection USP. These products came from lot 56-148-EV, expiring August 1, 2017.



about this drug recall >

On March 8, 2016

Teva Pharmaceuticals voluntarily recalled amikacin sulfate injection USP, 1 gram/4mL (250 mg/mL) vials from lot 4750915. This drug is used in the short term to treat severe infections.



about this drug recall >

On March 1, 2016

Sagent Pharmaceuticals, Inc voluntarily recalled Fluconazole Injection, USP, (in 0.9% Sodium Chloride) 200mg per 100mL flexible container bag because of a defect. This defect may decrease how effective the product is.



about this drug recall >

This plan, Navitus MedicareRx (PDP), is offered by Navitus Health Solutions and underwritten by Dean Health Insurance, Inc., A Federally-Qualified Medicare Contracting Prescription Drug Plan.